Molecule Can Curb Addicts' Cravings - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > VARIOUS DRUG RELATED TOPICS > Recovery and addiction
Register Tags Mark Forums Read

Notices

Recovery and addiction Support for coping with addiction and kicking the habit.

Reply
 
Thread Tools Display Modes
  #1  
Old 16-02-2006, 15:50
Alfa's Avatar
Alfa Alfa is nu online
Alfa is temporary not available
Productive insomniac
Administrator
 
Join Date: 14-01-2003
Location: Netherlands
Age: 94
Posts: 20,270
Blog Entries: 2
Alfa is a true resource and beyond reputeAlfa is a true resource and beyond reputeAlfa is a true resource and beyond reputeAlfa is a true resource and beyond reputeAlfa is a true resource and beyond reputeAlfa is a true resource and beyond reputeAlfa is a true resource and beyond reputeAlfa is a true resource and beyond reputeAlfa is a true resource and beyond reputeAlfa is a true resource and beyond reputeAlfa is a true resource and beyond repute
Points: 122,305, Level: 49 Points: 122,305, Level: 49 Points: 122,305, Level: 49
Activity: 73% Activity: 73% Activity: 73%
Molecule Can Curb Addicts' Cravings

MOLECULE CAN CURB ADDICTS' CRAVINGS
Blocking Agent Not Yet Tested In Humans
SASKATOON - A University of Saskatchewan-led team has developed an agent that could universally block a gamut of addictions, from nicotine to alcohol to cocaine.
But researchers don't know yet if the synthetic peptide that stemmed addiction to nicotine and marijuana in rats is safe or effective in humans.
In research published yesterday in the March edition of Nature Medicine, investigators show a molecule called PTEN interacts with receptors that in turn excite dopamine neurons --the cells responsible for signalling pleasure.
A synthetic peptide called Tat-3L4F interrupted that interaction and stopped rats from being addicted to both nicotine and marijuana.
Although only tested with nicotine and marijuana, Dr. Xia Zhang, associate professor of psychiatery at the University of Saskatchewan, said the treatment could work for a range of illicit drugs because they all act by exciting dopamine neurons in the ventral tegmental area of the brain.
In the study, rats were placed in a white box after receiving injections of addictive drugs, and placed in a black box on alternate days, when they received a placebo, or drugless, injection. Later, researchers placed the rats between the black and white boxes and recorded how much time they spent in each.
Rats who were addicted to nicotine or marijuana, but received the special interfering peptide, spent equal time in the black and white boxes, signalling they had kicked their addictions. Rats who didn't get the peptide spent most of their time in the white boxes.
Reply With Quote
  #2  
Old 16-02-2006, 16:39
pharmapsyche's Avatar
pharmapsyche pharmapsyche is offline
AKA Miss Methylene
Titanium Member
 
Join Date: 17-10-2005
Age: 22
Posts: 354
pharmapsyche is a captain of the SWIM team.pharmapsyche is a captain of the SWIM team.pharmapsyche is a captain of the SWIM team.
Points: 2,658, Level: 7 Points: 2,658, Level: 7 Points: 2,658, Level: 7
Activity: 0% Activity: 0% Activity: 0%
This is very interesting! It's cool how they believe that just one certian molecule, as you said, PTEN, interacts with receptors that in turn excite dopamine neurons. I would imagine that this molecule would work exteremly well for Meth-amphetamine and Amphetamine addicts, consdiering the fact that Amphetamines work by releasing dopamine. I can't wait to hear more on this subject.
For a little more information on drug addiction, i found this article which was published back in 1996, but it does help back up your article....

Addiction
David J Nutt
University of Bristol
Psychopharmacology Unit
School of Medical Sciences
University Walk, Bristol BS81TD, UK
(D J Nutt FRCPsych)
The Lancet 1996; 347: 31-36

The processes of addiction involve alterations in brain function because misused drugs are neuroactive substances that alter brain transmitter function. Then is an impressive and rapidly growing research base that is giving important insights into the neurochemical and molecular actions of drugs of misuse--the processes that are likely to determine such misuse in human beings. Exciting new developments in neuroimaging with both PET (positron emission tomography) and SPELT (single photon emission computed tomography) provide, for the first time, the possibility of testing in human beings theories of drug addiction derived from preclinical studies.

For most drugs of misuse, the molecular sites of action are receptors or transporter sites; many of these have been cloned and sequenced, discoveries which in themselves are important advances for molecular biology. The dopamine transporter was cloned to expedite the understanding of cocaine's action;5 all three of the opioid receptors and the multiple subunits of the γ-aminobutyric acid agonist A-type (GABA A) receptor have also been cloned. Such discoveries help direct research towards a more rational design of treatment, and help develop theories of the brain mechanisms underlying addiction. There is a large research effort being directed towards finding a drug that will bind to the dopamine transporter and prevent the binding, and hence the actions, of cocaine without interfering with dopamine uptake.

....looks like were on the right road to finding better addiction treatment!
Reply With Quote
Reply

Bookmarks

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


Sitelinks: Site Functions:

All times are GMT +1. The time now is 23:38.


Copyright: Substance Information Network 2003 - 2009, All rights reserved